Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29.
   PubMed Web of Science ®Google Scholar
• Réjiba S, Reddy LH, Bigand C, et al. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. Nanomedicine 2011;7:841–9.
   PubMed Web of Science ®Google Scholar
• Di Marco M, Di Cicilia R, Macchini M, et al. Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? (Review). Oncol Rep 2010;23:1183–92.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Hosotani R, Wada M, et al. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 1999;56:73–82.
   PubMed Web of Science ®Google Scholar
• Guoan X, Hanning W, Kaiyun C, Hao L. Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo. Surgery 2010;147:553–61.
   PubMed Web of Science ®Google Scholar
• Schulze-Bergkamen H, Fleischer B, Schuchmann M, et al. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer 2006;6:232.
   PubMed Web of Science ®Google Scholar
• Wei SH, Dong K, Lin F, et al. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell. Cancer Chemother Pharmacol 2008;62:1055–64.
   PubMed Web of Science ®Google Scholar
• Poon C, He C, Liu D, et al. Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer. J Control Release 2015;201:90–9.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li F, Li Y, et al. Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer. Biomaterials 2015;46:13–25.
   PubMed Web of Science ®Google Scholar
• Zanotto-Filho A, Braganhol E, Klafke K, et al. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. Cancer Lett 2015;358:220–31.
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013;369:1691–703.
   PubMed Web of Science ®Google Scholar
• Watkins DJ, Starling N, Cunningham D, et al. The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study. Eur J Cancer 2014;50:1422–9.
   PubMed Web of Science ®Google Scholar
• Lee SH, Ryu JK, Lee KY, et al. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett 2008;259:39–49.
   PubMed Web of Science ®Google Scholar
• Tsai MJ, Wu PC, Huang YB, et al. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm 2012;423:461–70.
   PubMed Web of Science ®Google Scholar
• Lee HZ, Leung HW, Lai MY, Wu CH. Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res 2005;25:959–64.
   PubMed Web of Science ®Google Scholar
• Lee DH, Kim C, Zhang L, Lee YJ. Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol 2008;75:2020–33.
   PubMed Web of Science ®Google Scholar
• Tong WG, Ding XZ, Adrian TE. The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Commun 2002;296:942–8.
   PubMed Web of Science ®Google Scholar
• Leung HW, Yang WH, Lai MY, et al. Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 2007;45:403–11.
   PubMed Web of Science ®Google Scholar
• Huang ST, Wang CY, Yang RC, et al. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells. Phytomedicine 2010;17:47–54.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Chen MC, Harris DM, et al. Anti-apoptotic BCL-2 family protein MCL-1 plays a critical role in baicalein-induced apoptosis in human pancreatic cancer cells. Gastroenterology 2011;140:S-68.
   Google Scholar
• Nakamura N, Hayasaka S, Zhang XY, et al. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappab binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp Eye Res 2003;77:195–202.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song L, Cai L, et al. Effects of baicalein on apoptosis, cell cycle arrest, migration and invasion of osteosarcoma cells . Food Chem Toxicol 2013;53:325–33.
   PubMed Web of Science ®Google Scholar
• Song X, Yao J, Wang F, et al. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. Toxicol Appl Pharmacol 2013;271:144–55.
   PubMed Web of Science ®Google Scholar
• Efferth T, Davey M, Olbrich A, et al. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol Dis 2002;28:160–8.
   PubMed Web of Science ®Google Scholar
• Tong WG, Ding XZ, Witt RC, Adrian TE. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 2002;1:929–35.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Chen MC, Pham H, et al. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim Biophys Acta 2011;1813:1465–74.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lin G, Chang Q, Zuo Z. Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharm Res 2005;22:1050–8.
   PubMed Web of Science ®Google Scholar
• Fong YK, Li CR, Wo SK, et al. In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein. J Ethnopharmacol 2012;141:742–53.
   PubMed Web of Science ®Google Scholar
• Seo MJ, Choi HS, Jeon HJ, et al. Baicalein inhibits lipid accumulation by regulating early adipogenesis and m-TOR signaling. Food Chem Toxicol 2014;67:57–64.
   PubMed Web of Science ®Google Scholar
• Tsai TH, Liu SC, Tsai PL, et al. The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study. Br J Pharmacol 2002;137:1314–20.
   PubMed Web of Science ®Google Scholar
• Mura S, Bui DT, Couvreur P, Nicolas J. Lipid prodrug nanocarriers in cancer therapy. J Control Release 2015;208:25–41.
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Sun BJ, He ZG. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends in Pharmacological Sciences 2014;35:556–66.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan W, Dai X, et al. Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles. Mol Pharm 2014;11:1140–50.
   PubMed Web of Science ®Google Scholar
• Byeon HJ, Choi SH, Choi JS, et al. Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer. Acta Biomater 2014;10:142–50.
   PubMed Web of Science ®Google Scholar
• Arpicco S, Lerda C, Dalla Pozza E, et al. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm 2013;85:373–80.
   PubMed Web of Science ®Google Scholar
• Ma Y, Fan X, Li L. pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel. Carbohydr Polym 2016;137:19–29.
   PubMed Web of Science ®Google Scholar
• Immordino ML, Brusa P, Rocco F, et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. J Control Release 2004;100:331–46.
   PubMed Web of Science ®Google Scholar
• Chen S, Liu W, Wan J, et al. Preparation of coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. Drug Dev Ind Pharm 2013;39:20–8.
   PubMed Web of Science ®Google Scholar
• Rajan M, Murugan M, Ponnamma D, et al. Poly-carboxylic acids functionalized chitosan nanocarriers for controlled and targeted anti-cancer drug delivery. Biomed Pharmacother 2016;83:201–11.
   PubMed Web of Science ®Google Scholar
• Zeng X, Tao W, Mei L, et al. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 2013;34:6058–67.
   PubMed Web of Science ®Google Scholar
• Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006;58:621–81.
   PubMed Web of Science ®Google Scholar
• Sloat BR, Sandoval MA, Li D, et al. In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles. Int J Pharm 2011;409:278–88.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xie Y, Sun H, et al. Effect of pore size of three-dimensionally ordered macroporous chitosan-silica matrix on solubility, drug release, and oral bioavailability of loaded-nimodipine. Drug Dev Ind Pharm 2016;42:464–72.
   PubMed Web of Science ®Google Scholar
• Sugahara S, Kajiki M, Kuriyama H, Kobayashi TR. Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs . Biol Pharm Bull 2002;25:632–41.
   PubMed Web of Science ®Google Scholar
• Danafar H, Rostamizadeh K, Davaran S, Hamidi M. PLA-PEG-PLA copolymer-based polymersomes as nanocarriers for delivery of hydrophilic and hydrophobic drugs: preparation and evaluation with atorvastatin and lisinopril . Drug Dev Ind Pharm 2014;40:1411–20.
   PubMed Web of Science ®Google Scholar
• Ruan S, Yuan M, Zhang L, et al. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials 2014;37:425–35. C:
   PubMed Web of Science ®Google Scholar
• Greenwald RB, Pendri A, BoIikal D, et al. Highly water soluble-taxol derivatives: 7-poly(ethylene glyc01) carbamates and carbonates. J Org Chem 1995;60:331–6.
   Web of Science ®Google Scholar
• Feng X, Yuan YJ, Wu JC. Synthesis and evaluation of water-soluble paclitaxel prodrugs. Bioorg Med Chem Lett 2002;12:3301–3.
   PubMed Web of Science ®Google Scholar
• Wang L, Luo Q, Lin T, et al. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Drug Dev Ind Pharm 2015;41:1204–12.
   PubMed Web of Science ®Google Scholar
• Shen CY, Li RS, Shen BD, et al. Influence of drug physicochemical characteristics on in vitro transdermal absorption of hydrophobic drug nanosuspensions. Drug Dev Ind Pharm 2015;41:1997–2005.
   PubMed Web of Science ®Google Scholar
• Fang YP, Lin YK, Su YH, Fang JY. Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core. Chem Pharm Bull (Tokyo) 2011;59:266–71.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine 2008;3:133–49.
   PubMed Web of Science ®Google Scholar
• Yang H, Cai W, Xu L, et al. Nanobubble-affibody: novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor. Biomaterials 2014;37:279–88.
   PubMed Web of Science ®Google Scholar
• Mahjub R, Radmehr M, Dorkoosh FA, et al. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations. Drug Dev Ind Pharm 2014;40:1645–59.
   PubMed Web of Science ®Google Scholar
• Shamma RN, Aburahma MH. Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia. Int J Nanomedicine 2014;9:5449–60.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen G, Zhang T, et al. Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation. Int J Nanomedicine 2014;9:5503–14.
   PubMed Web of Science ®Google Scholar
• Anirudhan TS, Binusreejayan. Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells. Int J Biol Macromol 2016;88:222–35.
   PubMed Web of Science ®Google Scholar
• Daman Z, Ostad S, Amini M, Gilani K. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles. Int J Pharm 2014;468:142–51.
   PubMed Web of Science ®Google Scholar
• Pingili R, Vemulapalli S, Mullapudi SS, et al. Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats. Drug Dev Ind Pharm 2015;4:1–33. [Epub ahead of print]
   Google Scholar
• Qu CY, Zhou M, Chen YW, et al. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy. Int J Nanomedicine 2015;10:3911–20.
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27–55.
   PubMedGoogle Scholar
• Li H, Chen M, Su Z, et al. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Int J Pharm 2016;511:524–37.
   PubMed Web of Science ®Google Scholar
• Xiong H, Du S, Ni J, et al. Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin. Biomaterials 2016;94:70–83.
   PubMed Web of Science ®Google Scholar
• Zhao S, Minh LV, Li N, et al. Doxorubicin hydrochloride-oleic acid conjugate-loaded nanostructured lipid carriers for tumor specific drug release. Colloids Surf B Biointerfaces 2016;145:95–103.
   PubMed Web of Science ®Google Scholar